Cerecin Pte. Ltd
http://www.cerecin.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Cerecin Pte. Ltd
Merck CEO Stresses Need For ‘Fair Return’ On COVID-19 Interventions
Merck & Co’s chief executive shares views on the need for “reasonable” returns on COVID-19 therapeutics and vaccines, and on the future US pricing environment, at the USAIC summit.
Merck Outlines COVID-19 Vaccine And Antiviral Plans As Pandemic Dents Q2 Sales
The expectation of a big second quarter sales decline proved true, but the situation is improving. Meanwhile, Merck & Co. is advancing two vaccines and an antiviral against the novel coronavirus.
Tech Transfer Roundup: Coronavirus Research Collaborations Respond To Pandemic
Recent collaborations involving Ridgeback, Themis, Junshi, Moleculin, Can-Fite, Pluristem and Beroni highlight the intense increase in research in how to treat or prevent COVID-19.
Asia Executives On The Move: Senior Changes At Biogen, Amicus, PhRMA In Japan, Ascletis and Lupin
The coming of autumn ushers in a flurry of executive changes. Biogen has a new R&D head for Japan while Amicus Japan has a new president, and other executive changes take place at Ascletis, Lupin and industry trade groups PhRMA and IPA.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Nutraceuticals
- Other Names / Subsidiaries
-
- Accera, Inc.
- Neuera Pharmaceuticals, Inc.